메뉴 건너뛰기




Volumn 64, Issue 13, 2014, Pages 1388-1400

Metabolic impairment in heart failure: The myocardial and systemic perspective

Author keywords

cachexia; insulin resistance; metabolism; muscle; sarcopenia; stroke

Indexed keywords

ALLOPURINOL; CARDIOVASCULAR AGENT; CARNITINE PALMITOYLTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE 2; CARNITINE PALMITOYLTRANSFERASE I; FATTY ACID; GLITAZONE DERIVATIVE; GROWTH HORMONE; INCRETIN; LIPOPROTEIN LIPASE; METFORMIN; PERHEXILINE; SAXAGLIPTIN; SZETO SCHILLER PEPTIDE; TRIMETAZIDINE; UNCLASSIFIED DRUG; STEROID;

EID: 84908294192     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.04.083     Document Type: Review
Times cited : (190)

References (124)
  • 1
    • 47849125899 scopus 로고    scopus 로고
    • Heart failure-related hospitalization in the U.S., 1979 to 2004
    • J. Fang, G.A. Mensah, and J.B. Croft Heart failure-related hospitalization in the U.S., 1979 to 2004 J Am Coll Cardiol 52 2008 428 434
    • (2008) J Am Coll Cardiol , vol.52 , pp. 428-434
    • Fang, J.1    Mensah, G.A.2    Croft, J.B.3
  • 2
    • 33747065311 scopus 로고    scopus 로고
    • Reduced peripheral skeletal muscle mass and abnormal reflex physiology in chronic heart failure
    • M.F. Piepoli, A. Kaczmarek, and D.P. Francis Reduced peripheral skeletal muscle mass and abnormal reflex physiology in chronic heart failure Circulation 114 2006 126 134
    • (2006) Circulation , vol.114 , pp. 126-134
    • Piepoli, M.F.1    Kaczmarek, A.2    Francis, D.P.3
  • 4
    • 33845565186 scopus 로고    scopus 로고
    • Nutrition, metabolism and the complex pathophysiology of cachexia in chronic heart failure
    • S. von Haehling, W. Doehner, and S.D. Anker Nutrition, metabolism and the complex pathophysiology of cachexia in chronic heart failure Cardiovasc Res 73 2007 298 309
    • (2007) Cardiovasc Res , vol.73 , pp. 298-309
    • Von Haehling, S.1    Doehner, W.2    Anker, S.D.3
  • 5
    • 0342460492 scopus 로고    scopus 로고
    • Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia
    • S.D. Anker, T.P. Chua, and P. Ponikowski Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia Circulation 96 1997 526 534
    • (1997) Circulation , vol.96 , pp. 526-534
    • Anker, S.D.1    Chua, T.P.2    Ponikowski, P.3
  • 6
    • 33750548421 scopus 로고    scopus 로고
    • Anabolic deficiency in men with chronic heart failure: Prevalence and detrimental impact on survival
    • E.A. Jankowska, B. Biel, and J. Majda Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival Circulation 114 2006 1829 1837
    • (2006) Circulation , vol.114 , pp. 1829-1837
    • Jankowska, E.A.1    Biel, B.2    Majda, J.3
  • 7
    • 50349087339 scopus 로고    scopus 로고
    • Insulin signaling and the general amino acid control response. Two distinct pathways to amino acid synthesis and uptake
    • S.E. Malmberg, and C.M. Adams Insulin signaling and the general amino acid control response. Two distinct pathways to amino acid synthesis and uptake J Biol Chem 283 2008 19229 19234
    • (2008) J Biol Chem , vol.283 , pp. 19229-19234
    • Malmberg, S.E.1    Adams, C.M.2
  • 8
    • 78649844780 scopus 로고    scopus 로고
    • Impaired muscle protein anabolic response to insulin and amino acids in heart failure patients: Relationship with markers of immune activation
    • M.J. Toth, M.M. LeWinter, and P.A. Ades Impaired muscle protein anabolic response to insulin and amino acids in heart failure patients: relationship with markers of immune activation Clin Sci (Lond) 119 2010 467 476
    • (2010) Clin Sci (Lond) , vol.119 , pp. 467-476
    • Toth, M.J.1    Lewinter, M.M.2    Ades, P.A.3
  • 9
    • 33747619854 scopus 로고    scopus 로고
    • Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling
    • X. Wang, Z. Hu, and J. Hu Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling Endocrinology 147 2006 4160 4168
    • (2006) Endocrinology , vol.147 , pp. 4160-4168
    • Wang, X.1    Hu, Z.2    Hu, J.3
  • 10
    • 0030751957 scopus 로고    scopus 로고
    • Insulin resistance in chronic heart failure: Relation to severity and etiology of heart failure
    • J.W. Swan, S.D. Anker, and C. Walton Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure J Am Coll Cardiol 30 1997 527 532
    • (1997) J Am Coll Cardiol , vol.30 , pp. 527-532
    • Swan, J.W.1    Anker, S.D.2    Walton, C.3
  • 11
    • 24944519346 scopus 로고    scopus 로고
    • Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure
    • W. Doehner, M. Rauchhaus, and P. Ponikowski Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure J Am Coll Cardiol 46 2005 1019 1026
    • (2005) J Am Coll Cardiol , vol.46 , pp. 1019-1026
    • Doehner, W.1    Rauchhaus, M.2    Ponikowski, P.3
  • 12
    • 7244254468 scopus 로고    scopus 로고
    • Impaired glucose metabolism in patients with heart failure: Pathophysiology and possible treatment strategies
    • A. Tenenbaum, and E.Z. Fisman Impaired glucose metabolism in patients with heart failure: pathophysiology and possible treatment strategies Am J Cardiovasc Drugs 4 2004 269 280
    • (2004) Am J Cardiovasc Drugs , vol.4 , pp. 269-280
    • Tenenbaum, A.1    Fisman, E.Z.2
  • 13
    • 0036230154 scopus 로고    scopus 로고
    • Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha
    • W. Doehner, M. Rauchhaus, and I.F. Godsland Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha Int J Cardiol 83 2002 73 81
    • (2002) Int J Cardiol , vol.83 , pp. 73-81
    • Doehner, W.1    Rauchhaus, M.2    Godsland, I.F.3
  • 14
    • 0035210722 scopus 로고    scopus 로고
    • Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia
    • W. Doehner, C.D. Pflaum, and M. Rauchhaus Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia Eur J Endocrinol 145 2001 727 735
    • (2001) Eur J Endocrinol , vol.145 , pp. 727-735
    • Doehner, W.1    Pflaum, C.D.2    Rauchhaus, M.3
  • 15
    • 0034897735 scopus 로고    scopus 로고
    • Acquired growth hormone resistance in patients with chronic heart failure: Implications for therapy with growth hormone
    • S.D. Anker, M. Volterrani, and C.D. Pflaum Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone J Am Coll Cardiol 38 2001 443 452
    • (2001) J Am Coll Cardiol , vol.38 , pp. 443-452
    • Anker, S.D.1    Volterrani, M.2    Pflaum, C.D.3
  • 16
    • 0032565361 scopus 로고    scopus 로고
    • Randomised, double blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy
    • K.J. Osterziel, O. Strohm, and J. Schuler Randomised, double blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy Lancet 351 1998 1233 1237
    • (1998) Lancet , vol.351 , pp. 1233-1237
    • Osterziel, K.J.1    Strohm, O.2    Schuler, J.3
  • 17
    • 67349180243 scopus 로고    scopus 로고
    • Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure
    • E.A. Jankowska, G. Filippatos, and B. Ponikowska Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure J Card Fail 15 2009 442 450
    • (2009) J Card Fail , vol.15 , pp. 442-450
    • Jankowska, E.A.1    Filippatos, G.2    Ponikowska, B.3
  • 18
    • 0035940390 scopus 로고    scopus 로고
    • Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: Relationships between ghrelin and anabolic/catabolic factors
    • N. Nagaya, M. Uematsu, and M. Kojima Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors Circulation 104 2001 2034 2038
    • (2001) Circulation , vol.104 , pp. 2034-2038
    • Nagaya, N.1    Uematsu, M.2    Kojima, M.3
  • 19
    • 60449091233 scopus 로고    scopus 로고
    • Resistin, adiponectin, and risk of heart failure the Framingham offspring study
    • D.S. Frankel, R.S. Vasan, and R.B. D'Agostino Sr. Resistin, adiponectin, and risk of heart failure the Framingham offspring study J Am Coll Cardiol 53 2009 754 762
    • (2009) J Am Coll Cardiol , vol.53 , pp. 754-762
    • Frankel, D.S.1    Vasan, R.S.2    D'Agostino, R.B.3
  • 20
    • 84894252588 scopus 로고    scopus 로고
    • Plasma adiponectin in heart failure with and without cachexia: Catabolic signal linking catabolism, symptomatic status, and prognosis
    • T. Szabó, N. Scherbakov, and A. Sandek Plasma adiponectin in heart failure with and without cachexia: catabolic signal linking catabolism, symptomatic status, and prognosis Nutr Metab Cardiovasc Dis 24 2014 50 56
    • (2014) Nutr Metab Cardiovasc Dis , vol.24 , pp. 50-56
    • Szabó, T.1    Scherbakov, N.2    Sandek, A.3
  • 21
    • 21244431648 scopus 로고    scopus 로고
    • Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans
    • A.L. Birkenfeld, M. Boschmann, and C. Moro Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans J Clin Endocrinol Metab 90 2005 3622 3628
    • (2005) J Clin Endocrinol Metab , vol.90 , pp. 3622-3628
    • Birkenfeld, A.L.1    Boschmann, M.2    Moro, C.3
  • 22
    • 34948814651 scopus 로고    scopus 로고
    • Altered intestinal function in patients with chronic heart failure
    • A. Sandek, J. Bauditz, and A. Swidsinski Altered intestinal function in patients with chronic heart failure J Am Coll Cardiol 50 2007 1561 1569
    • (2007) J Am Coll Cardiol , vol.50 , pp. 1561-1569
    • Sandek, A.1    Bauditz, J.2    Swidsinski, A.3
  • 23
    • 67651237070 scopus 로고    scopus 로고
    • Exercise training, energy metabolism, and heart failure
    • R. Ventura-Clapier Exercise training, energy metabolism, and heart failure Appl Physiol Nutr Metab 34 2009 336 339
    • (2009) Appl Physiol Nutr Metab , vol.34 , pp. 336-339
    • Ventura-Clapier, R.1
  • 24
    • 44649151707 scopus 로고    scopus 로고
    • The PPAR trio: Regulators of myocardial energy metabolism in health and disease
    • J.A. Madrazo, and D.P. Kelly The PPAR trio: regulators of myocardial energy metabolism in health and disease J Mol Cell Cardiol 44 2008 968 975
    • (2008) J Mol Cell Cardiol , vol.44 , pp. 968-975
    • Madrazo, J.A.1    Kelly, D.P.2
  • 25
    • 0038637236 scopus 로고    scopus 로고
    • Muscular levels of proinflammatory cytokines correlate with a reduced expression of insulinlike growth factor-I in chronic heart failure
    • P.C. Schulze, S. Gielen, and V. Adams Muscular levels of proinflammatory cytokines correlate with a reduced expression of insulinlike growth factor-I in chronic heart failure Basic Res Cardiol 98 2003 267 274
    • (2003) Basic Res Cardiol , vol.98 , pp. 267-274
    • Schulze, P.C.1    Gielen, S.2    Adams, V.3
  • 26
    • 14844292158 scopus 로고    scopus 로고
    • Muscle wastage in chronic heart failure, between apoptosis, catabolism and altered anabolism: A chimaeric view of inflammation?
    • L.D. Libera, and G. Vescovo Muscle wastage in chronic heart failure, between apoptosis, catabolism and altered anabolism: a chimaeric view of inflammation? Curr Opin Clin Nutr Metab Care 7 2004 435 441
    • (2004) Curr Opin Clin Nutr Metab Care , vol.7 , pp. 435-441
    • Libera, L.D.1    Vescovo, G.2
  • 27
    • 79958064409 scopus 로고    scopus 로고
    • Myostatin from the heart: Local and systemic actions in cardiac failure and muscle wasting
    • A. Breitbart, M. Auger-Messier, and J.D. Molkentin Myostatin from the heart: local and systemic actions in cardiac failure and muscle wasting Am J Physiol Heart Circ Physiol 300 2011 H1973 H1982
    • (2011) Am J Physiol Heart Circ Physiol , vol.300 , pp. 1973-H1982
    • Breitbart, A.1    Auger-Messier, M.2    Molkentin, J.D.3
  • 28
    • 11144247719 scopus 로고    scopus 로고
    • Loss of myostatin expression alters fiber-type distribution and expression of myosin heavy chain isoforms in slow- and fast-type skeletal muscle
    • S. Girgenrath, K. Song, and L.A. Whittemore Loss of myostatin expression alters fiber-type distribution and expression of myosin heavy chain isoforms in slow- and fast-type skeletal muscle Muscle Nerve 31 2005 34 40
    • (2005) Muscle Nerve , vol.31 , pp. 34-40
    • Girgenrath, S.1    Song, K.2    Whittemore, L.A.3
  • 29
    • 38749120993 scopus 로고    scopus 로고
    • Hypothesis: Myostatin is a mediator of cardiac cachexia
    • M.R. Hoenig Hypothesis: myostatin is a mediator of cardiac cachexia Int J Cardiol 124 2008 131 133
    • (2008) Int J Cardiol , vol.124 , pp. 131-133
    • Hoenig, M.R.1
  • 30
    • 0026554586 scopus 로고
    • Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure
    • D.M. Mancini, G. Walter, and N. Reichek Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure Circulation 85 1992 1364 1373
    • (1992) Circulation , vol.85 , pp. 1364-1373
    • Mancini, D.M.1    Walter, G.2    Reichek, N.3
  • 31
    • 0031539407 scopus 로고    scopus 로고
    • Skeletal muscle function and its relation to exercise tolerance in chronic heart failure
    • D. Harrington, S.D. Anker, and T.P. Chua Skeletal muscle function and its relation to exercise tolerance in chronic heart failure J Am Coll Cardiol 30 1997 1758 1764
    • (1997) J Am Coll Cardiol , vol.30 , pp. 1758-1764
    • Harrington, D.1    Anker, S.D.2    Chua, T.P.3
  • 32
    • 19044393872 scopus 로고    scopus 로고
    • Adipose tissue, inflammation, and cardiovascular disease
    • A.H. Berg, and P.E. Scherer Adipose tissue, inflammation, and cardiovascular disease Circ Res 96 2005 939 949
    • (2005) Circ Res , vol.96 , pp. 939-949
    • Berg, A.H.1    Scherer, P.E.2
  • 33
    • 33846621473 scopus 로고    scopus 로고
    • Fat loss in cachexia - Is there a role for adipocyte lipolysis?
    • M. Rydén, and P. Arner Fat loss in cachexia - is there a role for adipocyte lipolysis? Clin Nutr 26 2007 1 6
    • (2007) Clin Nutr , vol.26 , pp. 1-6
    • Rydén, M.1    Arner, P.2
  • 34
  • 35
    • 0033936322 scopus 로고    scopus 로고
    • Natriuretic peptides: A new lipolytic pathway in human adipocytes
    • C. Sengenès, M. Berlan, and I. De Glisezinski Natriuretic peptides: a new lipolytic pathway in human adipocytes FASEB J 14 2000 1345 1351
    • (2000) FASEB J , vol.14 , pp. 1345-1351
    • Sengenès, C.1    Berlan, M.2    De Glisezinski, I.3
  • 36
    • 42949109612 scopus 로고    scopus 로고
    • Control of lipolysis by natriuretic peptides and cyclic GMP
    • M. Lafontan, C. Moro, and M. Berlan Control of lipolysis by natriuretic peptides and cyclic GMP Trends Endocrinol Metab 19 2008 130 137
    • (2008) Trends Endocrinol Metab , vol.19 , pp. 130-137
    • Lafontan, M.1    Moro, C.2    Berlan, M.3
  • 37
    • 84885051569 scopus 로고    scopus 로고
    • Increased catabolic activity in adipose tissue of patients with chronic heart failure
    • T. Szabó, E. Postrach, and A. Mähler Increased catabolic activity in adipose tissue of patients with chronic heart failure Eur J Heart Fail 15 2013 1131 1137
    • (2013) Eur J Heart Fail , vol.15 , pp. 1131-1137
    • Szabó, T.1    Postrach, E.2    Mähler, A.3
  • 38
    • 20344400660 scopus 로고    scopus 로고
    • Adipocyte signaling and lipid homeostasis: Sequelae of insulin-resistant adipose tissue
    • Y.H. Yu, and H.N. Ginsberg Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue Circ Res 96 2005 1042 1052
    • (2005) Circ Res , vol.96 , pp. 1042-1052
    • Yu, Y.H.1    Ginsberg, H.N.2
  • 39
    • 25444506344 scopus 로고    scopus 로고
    • Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure
    • C. Kistorp, J. Faber, and S. Galatius Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure Circulation 112 2005 1756 1762
    • (2005) Circulation , vol.112 , pp. 1756-1762
    • Kistorp, C.1    Faber, J.2    Galatius, S.3
  • 40
    • 34548355070 scopus 로고    scopus 로고
    • Increase in serum adiponectin concentration in patients with heart failure and cachexia: Relationship with leptin, other cytokines, and B-type natriuretic peptide
    • M.B. McEntegart, B. Awede, and M.C. Petrie Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide Eur Heart J 28 2007 829 835
    • (2007) Eur Heart J , vol.28 , pp. 829-835
    • McEntegart, M.B.1    Awede, B.2    Petrie, M.C.3
  • 41
    • 0030852304 scopus 로고    scopus 로고
    • Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure
    • E. Shane, D. Mancini, and K. Aaronson Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure Am J Med 103 1997 197 207
    • (1997) Am J Med , vol.103 , pp. 197-207
    • Shane, E.1    Mancini, D.2    Aaronson, K.3
  • 42
    • 67649794856 scopus 로고    scopus 로고
    • Osteoporosis and congestive heart failure (CHF) in the elderly patient: Double disease burden
    • S. Abou-Raya, and A. Abou-Raya Osteoporosis and congestive heart failure (CHF) in the elderly patient: double disease burden Arch Gerontol Geriatr 49 2009 250 254
    • (2009) Arch Gerontol Geriatr , vol.49 , pp. 250-254
    • Abou-Raya, S.1    Abou-Raya, A.2
  • 43
    • 0033557630 scopus 로고    scopus 로고
    • Loss of bone mineral in patients with cachexia due to chronic heart failure
    • S.D. Anker, A.L. Clark, and M.M. Teixeira Loss of bone mineral in patients with cachexia due to chronic heart failure Am J Cardiol 83 1999 612 615
    • (1999) Am J Cardiol , vol.83 , pp. 612-615
    • Anker, S.D.1    Clark, A.L.2    Teixeira, M.M.3
  • 44
    • 62449231008 scopus 로고    scopus 로고
    • Bone mineral status and bone loss over time in men with chronic systolic heart failure and their clinical and hormonal determinants
    • E.A. Jankowska, J. Jakubaszko, and A. Cwynar Bone mineral status and bone loss over time in men with chronic systolic heart failure and their clinical and hormonal determinants Eur J Heart Fail 11 2009 28 38
    • (2009) Eur J Heart Fail , vol.11 , pp. 28-38
    • Jankowska, E.A.1    Jakubaszko, J.2    Cwynar, A.3
  • 45
    • 33644674991 scopus 로고    scopus 로고
    • Markers of bone metabolism in congestive heart failure
    • A. Zittermann, S.S. Schleithoff, and R. Koerfer Markers of bone metabolism in congestive heart failure Clin Chim Acta 366 2006 27 36
    • (2006) Clin Chim Acta , vol.366 , pp. 27-36
    • Zittermann, A.1    Schleithoff, S.S.2    Koerfer, R.3
  • 46
    • 77950034070 scopus 로고    scopus 로고
    • Relationship between high circulating adiponectin with bone mineral density and bone metabolism in elderly males with chronic heart failure
    • B. Bozic, G. Loncar, and N. Prodanovic Relationship between high circulating adiponectin with bone mineral density and bone metabolism in elderly males with chronic heart failure J Card Fail 16 2010 301 307
    • (2010) J Card Fail , vol.16 , pp. 301-307
    • Bozic, B.1    Loncar, G.2    Prodanovic, N.3
  • 47
    • 0036342402 scopus 로고    scopus 로고
    • Cardiac cachexia in early literature: A review of research prior to Medline
    • W. Doehner, and S.D. Anker Cardiac cachexia in early literature: a review of research prior to Medline Int J Cardiol 85 2002 7 14
    • (2002) Int J Cardiol , vol.85 , pp. 7-14
    • Doehner, W.1    Anker, S.D.2
  • 48
    • 0030972278 scopus 로고    scopus 로고
    • Wasting as independent risk factor for mortality in chronic heart failure
    • S.D. Anker, P. Ponikowski, and S. Varney Wasting as independent risk factor for mortality in chronic heart failure Lancet 349 1997 1050 1053
    • (1997) Lancet , vol.349 , pp. 1050-1053
    • Anker, S.D.1    Ponikowski, P.2    Varney, S.3
  • 49
    • 78650411136 scopus 로고    scopus 로고
    • Cachexia as a major underestimated and unmet medical need: Facts and numbers
    • S. von Haehling, and S.D. Anker Cachexia as a major underestimated and unmet medical need: facts and numbers J Cachexia Sarcopenia Muscle 1 2010 1 5
    • (2010) J Cachexia Sarcopenia Muscle , vol.1 , pp. 1-5
    • Von Haehling, S.1    Anker, S.D.2
  • 50
    • 77950340105 scopus 로고    scopus 로고
    • Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics."
    • M. Muscaritoli, S.D. Anker, and J. Argilés Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics." Clin Nutr 29 2010 154 159
    • (2010) Clin Nutr , vol.29 , pp. 154-159
    • Muscaritoli, M.1    Anker, S.D.2    Argilés, J.3
  • 51
    • 0037471843 scopus 로고    scopus 로고
    • Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: An observational study
    • S.D. Anker, A. Negassa, and A.J. Coats Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study Lancet 361 2003 1077 1083
    • (2003) Lancet , vol.361 , pp. 1077-1083
    • Anker, S.D.1    Negassa, A.2    Coats, A.J.3
  • 54
    • 33845299533 scopus 로고    scopus 로고
    • Etiology of anemia in patients with advanced heart failure
    • J.N. Nanas, C. Matsouka, and D. Karageorgopoulos Etiology of anemia in patients with advanced heart failure J Am Coll Cardiol 48 2006 2485 2489
    • (2006) J Am Coll Cardiol , vol.48 , pp. 2485-2489
    • Nanas, J.N.1    Matsouka, C.2    Karageorgopoulos, D.3
  • 55
    • 67149084949 scopus 로고    scopus 로고
    • Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: Diagnostic and therapeutic implications
    • I. Theurl, E. Aigner, and M. Theurl Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications Blood 113 2009 5277 5286
    • (2009) Blood , vol.113 , pp. 5277-5286
    • Theurl, I.1    Aigner, E.2    Theurl, M.3
  • 56
    • 77954249308 scopus 로고    scopus 로고
    • Two to tango: Regulation of Mammalian iron metabolism
    • M.W. Hentze, M.U. Muckenthaler, and B. Galy Two to tango: regulation of Mammalian iron metabolism Cell 142 2010 24 38
    • (2010) Cell , vol.142 , pp. 24-38
    • Hentze, M.W.1    Muckenthaler, M.U.2    Galy, B.3
  • 57
    • 2342510407 scopus 로고    scopus 로고
    • IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
    • E. Nemeth, S. Rivera, and V. Gabayan IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin J Clin Invest 113 2004 1271 1276
    • (2004) J Clin Invest , vol.113 , pp. 1271-1276
    • Nemeth, E.1    Rivera, S.2    Gabayan, V.3
  • 58
    • 65349173063 scopus 로고    scopus 로고
    • Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli
    • H. Huang, M. Constante, and A. Layoun Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli Blood 113 2009 3593 3599
    • (2009) Blood , vol.113 , pp. 3593-3599
    • Huang, H.1    Constante, M.2    Layoun, A.3
  • 59
    • 0037458095 scopus 로고    scopus 로고
    • Anemia is common in heart failure and is associated with poor outcomes: Insights from a cohort of 12 065 patients with new-onset heart failure
    • J.A. Ezekowitz, F.A. McAlister, and P.W. Armstrong Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure Circulation 107 2003 223 225
    • (2003) Circulation , vol.107 , pp. 223-225
    • Ezekowitz, J.A.1    McAlister, F.A.2    Armstrong, P.W.3
  • 60
    • 14744278436 scopus 로고    scopus 로고
    • Anemia of chronic disease
    • G. Weiss, and L.T. Goodnough Anemia of chronic disease N Engl J Med 352 2005 1011 1023
    • (2005) N Engl J Med , vol.352 , pp. 1011-1023
    • Weiss, G.1    Goodnough, L.T.2
  • 61
    • 72449156527 scopus 로고    scopus 로고
    • Ferric carboxymaltose in patients with heart failure and iron deficiency
    • for the FAIR-HF Trial Investigators
    • S.D. Anker, J. Comin Colet, G. Filippatos for the FAIR-HF Trial Investigators Ferric carboxymaltose in patients with heart failure and iron deficiency N Engl J Med 361 2009 2436 2448
    • (2009) N Engl J Med , vol.361 , pp. 2436-2448
    • Anker, S.D.1    Comin Colet, J.2    Filippatos, G.3
  • 62
    • 80155190205 scopus 로고    scopus 로고
    • Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure
    • E.A. Jankowska, P. Rozentryt, and A. Witkowska Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure J Card Fail 17 2011 899 906
    • (2011) J Card Fail , vol.17 , pp. 899-906
    • Jankowska, E.A.1    Rozentryt, P.2    Witkowska, A.3
  • 63
    • 33751177803 scopus 로고    scopus 로고
    • Iron-sulfur protein biogenesis in eukaryotes: Components and mechanisms
    • R. Lill, and U. Muhlenhoff Iron-sulfur protein biogenesis in eukaryotes: components and mechanisms Annu Rev Cell Dev Biol 22 2006 457 486
    • (2006) Annu Rev Cell Dev Biol , vol.22 , pp. 457-486
    • Lill, R.1    Muhlenhoff, U.2
  • 64
    • 80155135813 scopus 로고    scopus 로고
    • Mitochondrial mayhem: The mitochondrion as a modulator of iron metabolism and its role in disease
    • M.L. Huang, D.J. Lane, and D.R. Richardson Mitochondrial mayhem: the mitochondrion as a modulator of iron metabolism and its role in disease Antioxid Redox Signal 15 2011 3003 3019
    • (2011) Antioxid Redox Signal , vol.15 , pp. 3003-3019
    • Huang, M.L.1    Lane, D.J.2    Richardson, D.R.3
  • 65
    • 0035040884 scopus 로고    scopus 로고
    • Uric acid in cachectic and non-cachectic patients with chronic heart failure: Relationship to leg vascular resistance
    • W. Doehner, M. Rauchhaus, and V.G. Florea Uric acid in cachectic and non-cachectic patients with chronic heart failure: relationship to leg vascular resistance Am Heart J 141 2001 792 799
    • (2001) Am Heart J , vol.141 , pp. 792-799
    • Doehner, W.1    Rauchhaus, M.2    Florea, V.G.3
  • 66
    • 0037461111 scopus 로고    scopus 로고
    • Uric acid and survival in chronic heart failure: Validation and application in metabolic, functional, and hemodynamic staging
    • S.D. Anker, W. Doehner, and M. Rauchhaus Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging Circulation 107 2003 1991 1997
    • (2003) Circulation , vol.107 , pp. 1991-1997
    • Anker, S.D.1    Doehner, W.2    Rauchhaus, M.3
  • 67
    • 33645827323 scopus 로고    scopus 로고
    • The Seattle Heart Failure Model: Prediction of survival in heart failure
    • W.C. Levy, D. Mozaffarian, and D.T. Linker The Seattle Heart Failure Model: prediction of survival in heart failure Circulation 113 2006 1424 1433
    • (2006) Circulation , vol.113 , pp. 1424-1433
    • Levy, W.C.1    Mozaffarian, D.2    Linker, D.T.3
  • 68
    • 0031723208 scopus 로고    scopus 로고
    • Uric acid in chronic heart failure: A measure of the anaerobic threshold
    • F. Leyva, T.P. Chua, and S.D. Anker Uric acid in chronic heart failure: a measure of the anaerobic threshold Metabolism 47 1998 1156 1159
    • (1998) Metabolism , vol.47 , pp. 1156-1159
    • Leyva, F.1    Chua, T.P.2    Anker, S.D.3
  • 69
    • 0031779935 scopus 로고    scopus 로고
    • The glycolytic pathway to coronary heart disease: A hypothesis
    • F. Leyva, C.S. Wingrove, and I.F. Godsland The glycolytic pathway to coronary heart disease: a hypothesis Metabolism 47 1998 657 662
    • (1998) Metabolism , vol.47 , pp. 657-662
    • Leyva, F.1    Wingrove, C.S.2    Godsland, I.F.3
  • 70
    • 0027585643 scopus 로고
    • Subcellular distribution of xanthine oxidase during cardiac ischemia and reperfusion: An immunocytochemical study
    • M. Ashraf, and Z.Q. Samra Subcellular distribution of xanthine oxidase during cardiac ischemia and reperfusion: an immunocytochemical study J Submicrosc Cytol Pathol 25 1993 193 201
    • (1993) J Submicrosc Cytol Pathol , vol.25 , pp. 193-201
    • Ashraf, M.1    Samra, Z.Q.2
  • 71
    • 80054069941 scopus 로고    scopus 로고
    • Xanthine oxidase and uric acid in cardiovascular disease: Clinical impact and therapeutic options
    • W. Doehner, and U. Landmesser Xanthine oxidase and uric acid in cardiovascular disease: clinical impact and therapeutic options Semin Nephrol 31 2011 433 440
    • (2011) Semin Nephrol , vol.31 , pp. 433-440
    • Doehner, W.1    Landmesser, U.2
  • 72
    • 33846446393 scopus 로고    scopus 로고
    • Uric acid in CHF: Marker or player in a metabolic disease?
    • W. Doehner, S. von Haehling, and S.D. Anker Uric acid in CHF: marker or player in a metabolic disease? Int J Cardiol 115 2007 156 158
    • (2007) Int J Cardiol , vol.115 , pp. 156-158
    • Doehner, W.1    Von Haehling, S.2    Anker, S.D.3
  • 73
    • 76549098607 scopus 로고    scopus 로고
    • Uric acid-lowering treatment with benzbromarone in patients with heart failure: A double blind placebo-controlled cross-over preliminary study
    • K. Ogino, M. Kato, and Y. Furuse Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double blind placebo-controlled cross-over preliminary study Circ Heart Fail 3 2010 73 81
    • (2010) Circ Heart Fail , vol.3 , pp. 73-81
    • Ogino, K.1    Kato, M.2    Furuse, Y.3
  • 74
    • 35848962497 scopus 로고    scopus 로고
    • Lowering serum urate does not improve endothelial function in patients with type 2 diabetes
    • W.S. Waring, J.A. McKnight, and D.J. Webb Lowering serum urate does not improve endothelial function in patients with type 2 diabetes Diabetologia 50 2007 2572 2579
    • (2007) Diabetologia , vol.50 , pp. 2572-2579
    • Waring, W.S.1    McKnight, J.A.2    Webb, D.J.3
  • 75
    • 0034095332 scopus 로고    scopus 로고
    • Myocardial substrate metabolism influences left ventricular energetics in vivo
    • C. Korvald, O.P. Elvenes, and T. Myrmel Myocardial substrate metabolism influences left ventricular energetics in vivo Am J Physiol Heart Circ Physiol 278 2000 H1345 H1351
    • (2000) Am J Physiol Heart Circ Physiol , vol.278 , pp. 1345-H1351
    • Korvald, C.1    Elvenes, O.P.2    Myrmel, T.3
  • 76
    • 0028302261 scopus 로고
    • Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate
    • R.M. Bersin, C. Wolfe, and M. Kwasman Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate J Am Coll Cardiol 23 1994 1617 1624
    • (1994) J Am Coll Cardiol , vol.23 , pp. 1617-1624
    • Bersin, R.M.1    Wolfe, C.2    Kwasman, M.3
  • 77
    • 33751002633 scopus 로고    scopus 로고
    • Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure
    • H. Tuunanen, E. Engblom, and A. Naum Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure Circulation 114 2006 2130 2137
    • (2006) Circulation , vol.114 , pp. 2130-2137
    • Tuunanen, H.1    Engblom, E.2    Naum, A.3
  • 78
    • 77749273703 scopus 로고    scopus 로고
    • Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure
    • M. Halbirk, H. Nørrelund, and N. Møller Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure Am J Physiol Heart Circ Physiol 298 2010 H1096 H1102
    • (2010) Am J Physiol Heart Circ Physiol , vol.298 , pp. 1096-H1102
    • Halbirk, M.1    Nørrelund, H.2    Møller, N.3
  • 79
    • 28144459335 scopus 로고    scopus 로고
    • Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia
    • W.C. Stanley, E.E. Morgan, and H. Huang Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia Am J Physiol Heart Circ Physiol 289 2005 H2304 H2309
    • (2005) Am J Physiol Heart Circ Physiol , vol.289 , pp. 2304-H2309
    • Stanley, W.C.1    Morgan, E.E.2    Huang, H.3
  • 80
    • 0030602865 scopus 로고    scopus 로고
    • Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone
    • J.A. Kennedy, S.A. Unger, and J.D. Horowitz Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone Biochem Pharmacol 52 1996 273 280
    • (1996) Biochem Pharmacol , vol.52 , pp. 273-280
    • Kennedy, J.A.1    Unger, S.A.2    Horowitz, J.D.3
  • 81
    • 21144453386 scopus 로고    scopus 로고
    • Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure
    • V. Lionetti, A. Linke, and M.P. Chandler Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure Cardiovasc Res 66 2005 454 461
    • (2005) Cardiovasc Res , vol.66 , pp. 454-461
    • Lionetti, V.1    Linke, A.2    Chandler, M.P.3
  • 82
    • 70349658838 scopus 로고    scopus 로고
    • The metabolic modulators, Etomoxir and NVP-LAB121, fail to reverse pressure overload induced heart failure in vivo
    • M. Schwarzer, G. Faerber, and T. Rueckauer The metabolic modulators, Etomoxir and NVP-LAB121, fail to reverse pressure overload induced heart failure in vivo Basic Res Cardiol 104 2009 547 557
    • (2009) Basic Res Cardiol , vol.104 , pp. 547-557
    • Schwarzer, M.1    Faerber, G.2    Rueckauer, T.3
  • 83
    • 0033910352 scopus 로고    scopus 로고
    • First clinical trial with etomoxir in patients with chronic congestive heart failure
    • S. Schmidt-Schweda, and C. Holubarsch First clinical trial with etomoxir in patients with chronic congestive heart failure Clin Sci (Lond) 99 2000 27 35
    • (2000) Clin Sci (Lond) , vol.99 , pp. 27-35
    • Schmidt-Schweda, S.1    Holubarsch, C.2
  • 84
    • 34547800233 scopus 로고    scopus 로고
    • A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: The ERGO (etomoxir for the recovery of glucose) study
    • C.J. Holubarsch, M. Rohrbach, and M. Karrasch A double-blind randomized multicentre clinical trial to evaluate the efficacy and safety of two doses of etomoxir in comparison with placebo in patients with moderate congestive heart failure: the ERGO (etomoxir for the recovery of glucose) study Clin Sci (Lond) 113 2007 205 212
    • (2007) Clin Sci (Lond) , vol.113 , pp. 205-212
    • Holubarsch, C.J.1    Rohrbach, M.2    Karrasch, M.3
  • 85
    • 0022451358 scopus 로고
    • Perhexiline maleate treatment for severe angina pectoris-correlations with pharmacokinetics
    • J.D. Horowitz, S.T. Sia, and P.S. Macdonald Perhexiline maleate treatment for severe angina pectoris-correlations with pharmacokinetics Int J Cardiol 13 1986 219 229
    • (1986) Int J Cardiol , vol.13 , pp. 219-229
    • Horowitz, J.D.1    Sia, S.T.2    Macdonald, P.S.3
  • 86
    • 33644875657 scopus 로고    scopus 로고
    • Metabolic modulation with perhexiline in chronic heart failure: A randomized, controlled trial of short-term use of a novel treatment
    • L. Lee, R. Campbell, and M. Scheuermann-Freestone Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment Circulation 112 2005 3280 3288
    • (2005) Circulation , vol.112 , pp. 3280-3288
    • Lee, L.1    Campbell, R.2    Scheuermann-Freestone, M.3
  • 87
    • 78049509377 scopus 로고    scopus 로고
    • Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy
    • K. Abozguia, P. Elliott, and W. McKenna Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy Circulation 122 2010 1562 1569
    • (2010) Circulation , vol.122 , pp. 1562-1569
    • Abozguia, K.1    Elliott, P.2    McKenna, W.3
  • 88
    • 32044448471 scopus 로고    scopus 로고
    • Effect of the anti-anginal agent, perhexiline, on neutrophil, valvular and vascular superoxide formation
    • J.A. Kennedy, K. Beck-Oldach, and K. McFadden-Lewis Effect of the anti-anginal agent, perhexiline, on neutrophil, valvular and vascular superoxide formation Eur J Pharmacol 531 2006 13 19
    • (2006) Eur J Pharmacol , vol.531 , pp. 13-19
    • Kennedy, J.A.1    Beck-Oldach, K.2    McFadden-Lewis, K.3
  • 89
    • 84874470810 scopus 로고    scopus 로고
    • How does perhexiline modulate myocardial energetics and ameliorate redox stress (abstr)?
    • D.T. Ngo, N.E. Drury, and D. Pagano How does perhexiline modulate myocardial energetics and ameliorate redox stress (abstr)? Circulation 124 2011 A14461
    • (2011) Circulation , vol.124 , pp. 14461
    • Ngo, D.T.1    Drury, N.E.2    Pagano, D.3
  • 90
    • 70349616273 scopus 로고    scopus 로고
    • Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling
    • A.D. Balgi, B.D. Fonseca, and E. Donohue Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling PLoS One 4 2009 e7124
    • (2009) PLoS One , vol.4 , pp. 7124
    • Balgi, A.D.1    Fonseca, B.D.2    Donohue, E.3
  • 91
    • 0031827967 scopus 로고    scopus 로고
    • Beta-receptor blockade decreases carnitine palmitoyl transferase i activity in dogs with heart failure
    • A.R. Panchal, W.C. Stanley, and J. Kerner Beta-receptor blockade decreases carnitine palmitoyl transferase I activity in dogs with heart failure J Card Fail 4 1998 121 126
    • (1998) J Card Fail , vol.4 , pp. 121-126
    • Panchal, A.R.1    Stanley, W.C.2    Kerner, J.3
  • 92
    • 0035933194 scopus 로고    scopus 로고
    • Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure
    • T.R. Wallhaus, M. Taylor, and T.R. DeGrado Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure Circulation 103 2001 2441 2446
    • (2001) Circulation , vol.103 , pp. 2441-2446
    • Wallhaus, T.R.1    Taylor, M.2    Degrado, T.R.3
  • 93
    • 0029150294 scopus 로고
    • Effect of sulfo-N-succinimidyl palmitate on the rat heart: Myocardial long-chain fatty acid uptake and cardiac hypertrophy
    • Y. Kusaka, T. Tanaka, and F. Okamoto Effect of sulfo-N-succinimidyl palmitate on the rat heart: myocardial long-chain fatty acid uptake and cardiac hypertrophy J Mol Cell Cardiol 27 1995 1605 1612
    • (1995) J Mol Cell Cardiol , vol.27 , pp. 1605-1612
    • Kusaka, Y.1    Tanaka, T.2    Okamoto, F.3
  • 94
    • 0034678082 scopus 로고    scopus 로고
    • The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase
    • P.F. Kantor, A. Lucien, and R. Kozak The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase Circ Res 86 2000 580 588
    • (2000) Circ Res , vol.86 , pp. 580-588
    • Kantor, P.F.1    Lucien, A.2    Kozak, R.3
  • 95
    • 53449101397 scopus 로고    scopus 로고
    • Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy
    • H. Tuunanen, E. Engblom, and A. Naum Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy Circulation 118 2008 1250 1258
    • (2008) Circulation , vol.118 , pp. 1250-1258
    • Tuunanen, H.1    Engblom, E.2    Naum, A.3
  • 96
    • 84863243325 scopus 로고    scopus 로고
    • Additional use of trimetazidine in patients with chronic heart failure: A meta-analysis
    • L. Zhang, Y. Lu, and H. Jiang Additional use of trimetazidine in patients with chronic heart failure: a meta-analysis J Am Coll Cardiol 59 2012 913 922
    • (2012) J Am Coll Cardiol , vol.59 , pp. 913-922
    • Zhang, L.1    Lu, Y.2    Jiang, H.3
  • 97
    • 33645466318 scopus 로고    scopus 로고
    • Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure
    • G. Fragasso, G. Perseghin, and F. De Cobelli Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure Eur Heart J 27 2006 942 948
    • (2006) Eur Heart J , vol.27 , pp. 942-948
    • Fragasso, G.1    Perseghin, G.2    De Cobelli, F.3
  • 98
    • 84874063767 scopus 로고    scopus 로고
    • Ranolazine for the treatment of diastolic heart failure in patients with preserved ejection fraction: Results from the RALI-DHF study (abstr)
    • L. Maier, R. Wachter, and F. Edelmann Ranolazine for the treatment of diastolic heart failure in patients with preserved ejection fraction: results from the RALI-DHF study (abstr) J Am Coll Cardiol 59 2012 E865
    • (2012) J Am Coll Cardiol , vol.59 , pp. 865
    • Maier, L.1    Wachter, R.2    Edelmann, F.3
  • 99
    • 67149146438 scopus 로고    scopus 로고
    • Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): A multicentre, randomised open-label trial
    • for the RECORD Study Team
    • P.D. Home, S.J. Pocock, H. Beck-Nielsen for the RECORD Study Team Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised open-label trial Lancet 373 2009 2125 2135
    • (2009) Lancet , vol.373 , pp. 2125-2135
    • Home, P.D.1    Pocock, S.J.2    Beck-Nielsen, H.3
  • 100
    • 84870248203 scopus 로고    scopus 로고
    • Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: An analysis of the PROactive study population
    • W. Doehner, E. Erdmann, and R. Cairns Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population Int J Cardiol 162 2012 20 26
    • (2012) Int J Cardiol , vol.162 , pp. 20-26
    • Doehner, W.1    Erdmann, E.2    Cairns, R.3
  • 101
    • 13444272949 scopus 로고    scopus 로고
    • Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: An observational study
    • F.A. Masoudi, S.E. Inzucchi, and Y. Wang Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study Circulation 111 2005 583 590
    • (2005) Circulation , vol.111 , pp. 583-590
    • Masoudi, F.A.1    Inzucchi, S.E.2    Wang, Y.3
  • 102
    • 84867706737 scopus 로고    scopus 로고
    • The effect of metformin on insulin resistance and exercise parameters in patients with heart failure
    • A.K. Wong, R. Symon, and M.A. Alzadjali The effect of metformin on insulin resistance and exercise parameters in patients with heart failure Eur J Heart Fail 14 2012 1303 1310
    • (2012) Eur J Heart Fail , vol.14 , pp. 1303-1310
    • Wong, A.K.1    Symon, R.2    Alzadjali, M.A.3
  • 103
    • 0036791054 scopus 로고    scopus 로고
    • Metformin in patients with type 2 diabetes mellitus: Reconsideration of traditional contraindications
    • R. Rachmani, I. Slavachevski, and Z. Levi Metformin in patients with type 2 diabetes mellitus: reconsideration of traditional contraindications Eur J Intern Med 13 2002 428
    • (2002) Eur J Intern Med , vol.13 , pp. 428
    • Rachmani, R.1    Slavachevski, I.2    Levi, Z.3
  • 104
    • 84878018230 scopus 로고    scopus 로고
    • Metformin therapy and prognosis of patients with heart failure and new-onset diabetes mellitus. A propensity-matched study in the community
    • S.P. Romero, J.L. Andrey, and A. Garcia-Egido Metformin therapy and prognosis of patients with heart failure and new-onset diabetes mellitus. A propensity-matched study in the community Int J Cardiol 166 2013 404 412
    • (2013) Int J Cardiol , vol.166 , pp. 404-412
    • Romero, S.P.1    Andrey, J.L.2    Garcia-Egido, A.3
  • 105
    • 84883765959 scopus 로고    scopus 로고
    • Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
    • for the SAVOR-TIMI Steering Committee and Investigators
    • B.M. Scirica, D.L. Bhatt, E. Braunwald for the SAVOR-TIMI Steering Committee and Investigators Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus N Engl J Med 369 2013 1317 1326
    • (2013) N Engl J Med , vol.369 , pp. 1317-1326
    • Scirica, B.M.1    Bhatt, D.L.2    Braunwald, E.3
  • 106
    • 84885322271 scopus 로고    scopus 로고
    • Are users of sulphonylureas at the time of an acute coronary syndrome at risk of poorer outcomes?
    • J. Nagendran, G.Y. Oudit, and J.A. Bakal Are users of sulphonylureas at the time of an acute coronary syndrome at risk of poorer outcomes? Diabetes Obes Metab 15 2013 1022 1028
    • (2013) Diabetes Obes Metab , vol.15 , pp. 1022-1028
    • Nagendran, J.1    Oudit, G.Y.2    Bakal, J.A.3
  • 107
    • 21144434217 scopus 로고    scopus 로고
    • Extension of murine life span by overexpression of catalase targeted to mitochondria
    • S.E. Schriner, N.J. Linford, and G.M. Martin Extension of murine life span by overexpression of catalase targeted to mitochondria Science 308 2005 1909 1911
    • (2005) Science , vol.308 , pp. 1909-1911
    • Schriner, S.E.1    Linford, N.J.2    Martin, G.M.3
  • 108
    • 67649204729 scopus 로고    scopus 로고
    • Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging
    • D.F. Dai, L.F. Santana, and M. Vermulst Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging Circulation 119 2009 2789 2797
    • (2009) Circulation , vol.119 , pp. 2789-2797
    • Dai, D.F.1    Santana, L.F.2    Vermulst, M.3
  • 109
    • 4544370680 scopus 로고    scopus 로고
    • Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury
    • K. Zhao, G.M. Zhao, and D. Wu Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury J Biol Chem 279 2004 34682 34690
    • (2004) J Biol Chem , vol.279 , pp. 34682-34690
    • Zhao, K.1    Zhao, G.M.2    Wu, D.3
  • 110
    • 79959525058 scopus 로고    scopus 로고
    • Mitochondrial targeted antioxidant peptide ameliorates hypertensive cardiomyopathy
    • D.F. Dai, T. Chen, and H. Szeto Mitochondrial targeted antioxidant peptide ameliorates hypertensive cardiomyopathy J Am Coll Cardiol 58 2011 73 82
    • (2011) J Am Coll Cardiol , vol.58 , pp. 73-82
    • Dai, D.F.1    Chen, T.2    Szeto, H.3
  • 111
    • 84883807865 scopus 로고    scopus 로고
    • Mitochondrial-targeted peptide rapidly improves mitochondrial energetics and skeletal muscle performance in aged mice
    • M.P. Siegel, S.E. Kruse, and J.M. Percival Mitochondrial-targeted peptide rapidly improves mitochondrial energetics and skeletal muscle performance in aged mice Aging Cell 12 2013 763 771
    • (2013) Aging Cell , vol.12 , pp. 763-771
    • Siegel, M.P.1    Kruse, S.E.2    Percival, J.M.3
  • 112
    • 84887454400 scopus 로고    scopus 로고
    • Global proteomics and pathway analysis of pressure-overload-induced heart failure and its attenuation by mitochondrial-targeted peptides
    • D.F. Dai, E.J. Hsieh, and T. Chen Global proteomics and pathway analysis of pressure-overload-induced heart failure and its attenuation by mitochondrial-targeted peptides Circ Heart Fail 6 2013 1067 1076
    • (2013) Circ Heart Fail , vol.6 , pp. 1067-1076
    • Dai, D.F.1    Hsieh, E.J.2    Chen, T.3
  • 113
    • 0026610468 scopus 로고
    • Therapy with coenzyme Q10 of patients in heart failure who are eligible or ineligible for a transplant
    • K. Folkers, P. Langsjoen, and P.H. Langsjoen Therapy with coenzyme Q10 of patients in heart failure who are eligible or ineligible for a transplant Biochem Biophys Res Commun 182 1992 247 253
    • (1992) Biochem Biophys Res Commun , vol.182 , pp. 247-253
    • Folkers, K.1    Langsjoen, P.2    Langsjoen, P.H.3
  • 114
    • 33750134250 scopus 로고    scopus 로고
    • The impact of coenzyme Q10 on systolic function in patients with chronic heart failure
    • S. Sander, C.I. Coleman, and A.A. Patel The impact of coenzyme Q10 on systolic function in patients with chronic heart failure J Card Fail 12 2006 464 472
    • (2006) J Card Fail , vol.12 , pp. 464-472
    • Sander, S.1    Coleman, C.I.2    Patel, A.A.3
  • 115
    • 84857275217 scopus 로고    scopus 로고
    • Allopurinol acutely increases adenosine triphospate energy delivery in failing human hearts
    • G.A. Hirsch, P.A. Bottomley, and G. Gerstenblith Allopurinol acutely increases adenosine triphospate energy delivery in failing human hearts J Am Coll Cardiol 59 2012 802 808
    • (2012) J Am Coll Cardiol , vol.59 , pp. 802-808
    • Hirsch, G.A.1    Bottomley, P.A.2    Gerstenblith, G.3
  • 116
    • 20044363683 scopus 로고    scopus 로고
    • Xanthine oxidase inhibition for chronic heart failure: Is allopurinol the next therapeutic advance in heart failure?
    • W. Doehner, and S.D. Anker Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure? Heart 91 2005 707 709
    • (2005) Heart , vol.91 , pp. 707-709
    • Doehner, W.1    Anker, S.D.2
  • 117
    • 68949215869 scopus 로고    scopus 로고
    • Association between allopurinol and mortality in heart failure patients: A long-term follow-up study
    • L. Wei, T. Fahey, and A.D. Struthers Association between allopurinol and mortality in heart failure patients: a long-term follow-up study Int J Clin Pract 63 2009 1327 1333
    • (2009) Int J Clin Pract , vol.63 , pp. 1327-1333
    • Wei, L.1    Fahey, T.2    Struthers, A.D.3
  • 118
    • 44649122196 scopus 로고    scopus 로고
    • Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study
    • for the OPT-CHF Investigators
    • J.M. Hare, B. Mangal, J. Brown for the OPT-CHF Investigators Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study J Am Coll Cardiol 51 2008 2301 2309
    • (2008) J Am Coll Cardiol , vol.51 , pp. 2301-2309
    • Hare, J.M.1    Mangal, B.2    Brown, J.3
  • 119
    • 0029817697 scopus 로고    scopus 로고
    • Hemodynamic effects of creatine phosphate in patients with congestive heart failure: A double-blind comparison trial versus placebo
    • S. Ferraro, C. Codella, and F. Palumbo Hemodynamic effects of creatine phosphate in patients with congestive heart failure: a double-blind comparison trial versus placebo Clin Cardiol 19 1996 699 703
    • (1996) Clin Cardiol , vol.19 , pp. 699-703
    • Ferraro, S.1    Codella, C.2    Palumbo, F.3
  • 120
    • 79953698833 scopus 로고    scopus 로고
    • Coenzyme Q10 terclatrate and creatine in chronic heart failure: A randomized, placebo-controlled, double-blind study
    • S. Fumagalli, F. Fattirolli, and L. Guarducci Coenzyme Q10 terclatrate and creatine in chronic heart failure: a randomized, placebo-controlled, double-blind study Clin Cardiol 34 2011 211 217
    • (2011) Clin Cardiol , vol.34 , pp. 211-217
    • Fumagalli, S.1    Fattirolli, F.2    Guarducci, L.3
  • 121
    • 0025639897 scopus 로고
    • Myocardial free carnitine and fatty acylcarnitine levels in patients with chronic heart failure
    • Y. Masumura, A. Kobayashi, and N. Yamazaki Myocardial free carnitine and fatty acylcarnitine levels in patients with chronic heart failure Jpn Circ J 54 1990 1471 1476
    • (1990) Jpn Circ J , vol.54 , pp. 1471-1476
    • Masumura, Y.1    Kobayashi, A.2    Yamazaki, N.3
  • 122
    • 84880197534 scopus 로고    scopus 로고
    • L-carnitine in the secondary prevention of cardiovascular disease: Systematic review and meta-analysis
    • J.J. DiNicolantonio, C.J. Lavie, and H. Fares L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis Mayo Clin Proc 88 2013 544 551
    • (2013) Mayo Clin Proc , vol.88 , pp. 544-551
    • Dinicolantonio, J.J.1    Lavie, C.J.2    Fares, H.3
  • 123
    • 28944442442 scopus 로고    scopus 로고
    • Testosterone therapy in men with moderate severity heart failure: A double-blind randomized placebo controlled trial
    • C.J. Malkin, P.J. Pugh, and J.N. West Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial Eur Heart J 27 2006 57 64
    • (2006) Eur Heart J , vol.27 , pp. 57-64
    • Malkin, C.J.1    Pugh, P.J.2    West, J.N.3
  • 124
    • 84864477617 scopus 로고    scopus 로고
    • ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
    • J.J. McMurray, S. Adamopoulos, and S.D. Anker ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 Eur J Heart Fail 14 2012 803 869
    • (2012) Eur J Heart Fail , vol.14 , pp. 803-869
    • McMurray, J.J.1    Adamopoulos, S.2    Anker, S.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.